Global Tuberculosis Report -- 2012.pdf

More documents

Recommendations

Info

–% OF TB PATIENTS WITHKNOWN HIV STATUS2005–2011YEAR% OF TBPATIENTS WITHKNOWN HIVSTATUSNUMBER OF TBPATIENTS WITHKNOWN HIVSTATUSPATIENTSNOTIFIED(NEW ANDRETREAT)NUMBER OFHIV-POSITIVETB PATIENTS% OF TESTEDTB PATIENTSHIV-POSITIVE% OF HIV-POSITIVE TBPATIENTS ONCPT% OF HIV-POSITIVE TBPATIENTS ONARTNUMBER OFHIV-POSITIVEPEOPLEPROVIDED IPTMalawi 2005 44 12 243 27 610 8 447 69 92 492009 86 21 041 24 356 13 558 64 94 45 02010 88 19 855 22 536 12 476 63 94 46• 44 83 • 2011 83 17 339 20 854 10 341 60 89 60Mali 2005 4 8842009 55 3 760 6 835 585 16 100 10 02010 42 2 303 5 448 416 18 75 52 0– 35 • 2011 35 1 963 5 573 440 22 66 63Mauritania 2005 0 10 2 218 0 02009 11 281 2 664 27 102010 24 608 2 489 90 15 61 0• 0 1 • 2011 1 12 1 820 12 100 100Mauritius 2005 91 115 127 2 2 100 502009 95 110 116 7 6 100 71 02010 95 117 123 8 7 100 75• 91 93 • 2011 93 108 116 8 7 100 62Mozambique 2005 33 7182009 84 38 087 45 529 25 056 66 89 22 2 4292010 88 40 554 46 174 24 574 61 97 25 13 164– 88 • 2011 88 41 896 47 452 26 538 63 91 29 17 064Namibia 2005 16 2 547 15 894 1 465 582009 74 9 849 13 332 5 676 58 78 35 17 7372010 76 9 534 12 625 5 227 55 93 44 13 989• 16 84 • 2011 84 10 042 11 938 4 990 50 98 54 14 428Niger 2005 8 224 152 43 342009 24 2 424 10 228 403 17 24 02010 48 4 925 10 345 405 8 37 0– 44 • 2011 44 4 710 10 714 334 7Nigeria 2005 10 6 897 66 848 1 241 182009 75 70 693 94 114 18 087 26 48 39 1 8532010 79 71 844 90 447 17 736 25 59 33 1 750• 10 81 • 2011 81 75 772 93 050 19 553 26 68 43 1 107Rwanda 2005 65 5 003 7 680 2 276 45 15 132009 97 7 448 7 644 2 529 34 92 63 02010 98 6 914 7 065 2 199 32 97 72• 65 97 • 2011 97 6 560 6 784 1 855 28 97 80Sao Tome and 2005 100 152 152 5 3 0 0Principe 2009 100 79 79 10 13 100 30 22010 92 112 122 13 12 92 54 0• 100 100 • 2011 100 146 146 14 10 100 100 0Senegal 2005 10 1202009 59 6 906 11 732 455 7 85 27 02010 69 8 018 11 591 776 10 85 37– 76 • 2011 76 8 757 11 588 877 10 85 48Seychelles 2005 14 2 100 1002009 100 15 15 3 20 100 100 02010 100 17 17 1 6 100 100 0– 100 • 2011 100 21 21 4 19 100 100Sierra Leone 2005 6 9302009 73 8 625 11 826 987 11 7 132010 74 9 718 13 195 976 10 6 19– 78 • 2011 78 10 159 12 943 902 9 25 28South Africa 2005 22 67 988 302 467 35 299 52 100 33 1 4662009 49 197 448 405 982 114 523 58 71 42 23 5832010 54 213 006 396 554 128 457 60 74 54 146 247• 22 83 • 2011 83 323 440 389 974 211 800 65 76 44 372 994Swaziland 2005 8 8642009 97 10 730 11 032 8 889 83 94 26 2 1072010 86 9 536 11 146 7 788 82 93 35– 92 • 2011 92 8 419 9 180 6 480 77 95 51Togo 2005 0 0 2 635 0 02009 56 1 734 3 093 342 20 74 36 02010 77 2 242 2 897 632 28 72 49• 0 84 • 2011 84 2 513 2 980 667 27 37 30Uganda 2005 25 10 555 41 809 7 523 71 25 102009 71 31 695 44 335 17 131 54 86 222010 81 36 742 45 546 19 836 54 90 24• 25 80 • 2011 80 39 394 49 018 20 725 53 93 32United Republic 2005 3 1 613 64 200 841 52 61 22of Tanzania 2009 88 56 388 64 267 21 541 38 89 31 1532010 90 56 849 63 453 21 662 38 92 35• 3 88 • 2011 88 53 531 61 148 20 525 38 95 38Zambia 2005 2 1 082 53 267 614 57 682009 77 34 992 45 551 23 584 67 64 422010 84 40 704 48 616 26 571 65 75 48• 2 86 • 2011 86 41 701 48 594 26 737 64 87 53Zimbabwe 2005 0 0 54 891 02009 62 28 952 46 453 22 745 79 92 382010 86 41 062 47 557 31 849 78 88 45• 0 86 • 2011 86 35 361 41 305 21 125 60 29 67 0AFRICAN REGIONGLOBAL TUBERCULOSIS REPORT 2012 Data can be downloaded from www.who.int/tb/data 165
YEARTOTALCONFIRMEDCASES OFMDR-TB aESTIMATED CASESOF MDR-TB AMONGNOTIFIEDESTIMATED CASESOF MDR-TB AMONGNOTIFIEDNEW PULMONARY CASESNUMBER OFBACT+VE bTESTED FORMDR-TB% OFBACT+VE bTESTED FORMDR-TBESTIMATED CASESOF MDR-TB AMONGNOTIFIEDPREVIOUSLY TREATED CASESNUMBER OF% OF NOTIFIEDNOTIFIEDTESTED FORTESTED FORMDR-TBMDR-TBAlgeria 2005 74 809 9.1 164 232009 – –2010 56 – –2011 190 (71–310) 130 (58–260) – 55 (6.8–180) –Angola 2005 – –2009 – –2010 3 – –2011 40 1 600 (800–2 400) 720 (200–1 200) 29 0.13 850 (290–1 400) –Benin 2005 28 31 1.1 107 322009 14 – 94 352010 15 103 3.5 6 2.92011 20 53 (24–81) 18 (2.2–73) 0 0 34 (22–51) 152 58Botswana 2005 – –2009 101 268 6.5 251 222010 106 488 11 286 272011 46 170 (110–230) 120 (70–160) 151 4.5 57 (21–93) 90 10Burkina Faso 2005 3 – 126 392009 19 3
Page 2 and 3:
GLOBALTUBERCULOSISREPORT2012
Page 4 and 5:
ContentsAbbreviationsivAcknowledgem
Page 6 and 7:
AcknowledgementsThis report on glob
Page 8 and 9:
WHO Western Pacific RegionShalala A
Page 10 and 11:
Executive SummaryThe World Health O
Page 12 and 13:
CHAPTER 1IntroductionBOX 1.1Basic f
Page 14 and 15:
TABLE 1.1 Targets for the scale-up
Page 16 and 17:
TABLE 1.2 Reporting of data in the
Page 18 and 19:
BOX 2.1Uncertainty in estimates of
Page 20 and 21:
TABLE 2.2 Estimated burden of disea
Page 22 and 23:
FIGURE 2.5 Estimated TB incidence r
Page 24 and 25:
FIGURE B2.2.1Reporting of notificat
Page 26 and 27:
FIGURE 2.8Estimated TB incidence ra
Page 28 and 29:
FIGURE 2.11 Countries (in blue) for
Page 30 and 31:
FIGURE 2.12 Trends in estimated TB
Page 32 and 33:
● producing and widely disseminat
Page 34 and 35:
FIGURE 2.16 Progress in global cove
Page 36 and 37:
BOX 2.6Efforts by the Task Force to
Page 38 and 39:
CHAPTER 3TB case notificationsand t
Page 40 and 41:
BOX 3.1 1Definitions of TB casesDef
Page 42 and 43:
TABLE 3.3 Contribution of public-pr
Page 44 and 45:
BOX 3.4Integrating community-based
Page 46 and 47:
TABLE 3.4 Estimates of the case det
Page 48 and 49:
TABLE 3.5 Treatment success for new
Page 50 and 51:
CHAPTER 4Drug-resistant TBKEY FACTS
Page 52 and 53:
FIGURE 4.2 Percentage of new TB cas
Page 54 and 55:
BOX 4.1Frequencies of resistance to
Page 56 and 57:
FIGURE 4.6 Number of MDR-TB cases e
Page 58 and 59:
FIGURE 4.7Notified cases of MDR-TB
Page 60 and 61:
egimens globally, providing more su
Page 62 and 63:
5.1 Funding for TB care and control
Page 64 and 65:
TABLE 5.2 NTP budgets, available fu
Page 66 and 67:
FIGURE 5.5Trends in domestic and do
Page 68 and 69:
FIGURE 5.6Domestic funding as a per
Page 70 and 71:
FIGURE 5.8Cost per TB patient succe
Page 72 and 73:
FIGURE 5.10 Total cost and unit cos
Page 74 and 75:
● The 14 countries not included i
Page 76 and 77:
on public health by an external Exp
Page 78 and 79:
evised as a result of the introduct
Page 80 and 81:
TABLE 6.2 Incorporation of WHO poli
Page 82 and 83:
FIGURE 6.3The Supranational Referen
Page 84 and 85:
of TB disease by 65%, irrespective
Page 86 and 87:
FIGURE 7.3Percentage of TB patients
Page 88 and 89:
BOX 7.1Accelerating progress in pro
Page 90 and 91:
TABLE 7.2 Assumptions used to estim
Page 92 and 93:
FIGURE 8.1 The development pipeline
Page 94 and 95:
sputum specimens and TB isolates fr
Page 96 and 97:
cal trial sites and building labora
Page 98:
new TB vaccine candidate. A Phase I
Page 102 and 103:
This annex explains the methods tha
Page 104 and 105:
2011. On average, 15 data points we
Page 106 and 107:
may suffer from biases. These biase
Page 108 and 109:
TABLE A1.3Parameter estimates used
Page 110 and 111:
5. Estimates of TB prevalence, 1990
Page 112:
the Republic of Moldova, Romania, t
Page 116 and 117:
AFGHANISTANPopulation 2011 32 milli
Page 118 and 119:
BRAZILPopulation 2011 197 millionHI
Page 120 and 121:
CHINAPopulation 2011 1 348 millionH
Page 122 and 123:
ETHIOPIAPopulation 2011 85 millionH
Page 124 and 125: INDONESIAPopulation 2011 242 millio
Page 126 and 127: MOZAMBIQUEPopulation 2011 24 millio
Page 128 and 129: NIGERIAPopulation 2011 162 millionH
Page 130 and 131: PHILIPPINESPopulation 2011 95 milli
Page 132 and 133: SOUTH AFRICAPopulation 2011 50 mill
Page 134 and 135: UGANDAPopulation 2011 35 millionHIG
Page 136 and 137: VIET NAMPopulation 2011 89 millionH
Page 138: ANNEX 3Regional profiles
Page 141 and 142: WHO REGION OF THE AMERICASPopulatio
Page 143 and 144: WHO EUROPEAN REGIONPopulation 2011
Page 145 and 146: WHO WESTERN PACIFIC REGIONPopulatio
Page 148 and 149: SUMMARY BY WHO REGIONTable A4.1 Est
Page 150 and 151: MORTALITY (EXCLUDING HIV) PREVALENC
Page 152 and 153: NEW AND RELAPSENOTIFICATION RATE aY
Page 154 and 155: -% OF TB PATIENTS WITHKNOWN HIV STA
Page 156 and 157: AFRICAN REGIONTable A4.1 Estimates
Page 162 and 163: INCIDENCE (INCLUDING HIV) INCIDENCE
Page 164 and 165: NEW AND RELAPSENOTIFICATION RATE aY
Page 166 and 167: NEW AND RELAPSENOTIFICATION RATE a1
Page 168 and 169: TREATMENT SUCCESS (%) a1995-2010YEA
Page 176 and 177: YEARTOTALCONFIRMEDCASES OFMDR-TB aE
Page 178 and 179: MALEYEAR 0-14 15-24 25-34 35-44 45-
Page 180 and 181: REGION OF THE AMERICASTable A4.1 Es
Page 192 and 193: % OF COHORTTREATMENT SUCCESS (%) a1
Page 200 and 201: YEARTOTALCONFIRMEDCASES OFMDR-TB aE
Page 202 and 203: MALEFEMALEYEAR 0-14 15-24 25-34 35-
Page 204 and 205: EASTERN MEDITERRANEAN REGIONTable A
Page 218 and 219: MALEFEMALEYEAR 0-14 15-24 25-34 35-
Page 220 and 221: EUROPEAN REGIONTable A4.1 Estimates
Page 224 and 225:
MORTALITY (EXCLUDING HIV) PREVALENC
Page 226 and 227:
INCIDENCE (INCLUDING HIV) INCIDENCE
Page 228 and 229:
INCIDENCE (INCLUDING HIV) INCIDENCE
Page 230 and 231:
NEW AND RELAPSENOTIFICATION RATE a1
Page 232 and 233:
Page 234 and 235:
% OF COHORTTREATMENT SUCCESS (%) a1
Page 236 and 237:
Page 238 and 239:
Page 240 and 241:
-% OF TB PATIENTS WITHKNOWN HIV STA
Page 242 and 243:
YEARTOTALCONFIRMEDCASES OFMDR-TB aE
Page 244 and 245:
MALEFEMALEYEAR 0-14 15-24 25-34 35-
Page 246 and 247:
Page 248 and 249:
SOUTH-EAST ASIA REGIONTable A4.1 Es
Page 250 and 251:
MORTALITY (EXCLUDING HIV) PREVALENC
Page 252 and 253:
Page 254 and 255:
Page 256 and 257:
Page 258:
SMEAR LABS % OF SMEARPER 100K LABS
Page 261 and 262:
Estimates of mortality, prevalence
Page 263 and 264:
YEARPOPULATION(MILLIONS)MORTALITY (
Page 265 and 266:
YEARPOPULATION(MILLIONS)INCIDENCE (
Page 267 and 268:
YEARPOPULATION(MILLIONS)INCIDENCE (
Page 269 and 270:
Page 271 and 272:
TREATMENT SUCCESS (%) a1995-2010YEA
Page 273 and 274:
TREATMENT SUCCESS (%) a1995-2010YEA
Page 275 and 276:
-% OF TB PATIENTS WITHKNOWN HIV STA
Page 277 and 278:
Page 279 and 280:
Page 281 and 282:
SMEAR LABS % OF SMEARPER 100K LABS
show all

Global Tuberculosis Report -- 2012.pdf

Create successful ePaper yourself

Delete template?

Save as template?